The effect of herbal drugs (Echinacea and Ginger) on Improvement of clinical symptoms and hospitalizations in suspected COVID-19 outpatient cases

Authors
Category Primary study
Registry of TrialsIranian Registry of Clinical Trials
Year 2020
INTERVENTION: Intervention group: In this study, 2 herbal medicines (in addition to standard treatment) will be used as follows. 1. Vomigone 500 tablets (containing ginger) 2 TDS a day (after meals)Â With drug registration number: 9406633051781240 Dineh Pharmaceutical Company .2 Rucoldup tablets 750 (containing echinacea) 1 tablet TDS day with drug registration number: 6563916081842893 Company: Ghaem Daru. CONDITION: COVID 19. ; U07.1 U07.1 PRIMARY OUTCOME: Improvement of clinical symptoms. Timepoint: Start of study and 7 days after study. Method of measurement: Questionnaire ‐ telephone follow‐up and. SECONDARY OUTCOME: Hospitalizations. Timepoint: 7 and 14 days after study. Method of measurement: Telephone follow up. INCLUSION CRITERIA: suspected COVID‐19 outpatient cases according to the flowchart for the Diagnosis and Treatment of 19 COVID Diseases of the Ministry of Health, Age between 18 and 65 years, Signing a Informed Consent
Epistemonikos ID: c404c339b9ba634d8162c52f5394cf27cac5e56a
First added on: Apr 23, 2020